J Allison-T Honjo 1996/2002 (Nobel 2018) CTLA-4 + PD-1 inhibition; modern modern ipilimumab + nivolumab + 2024 LAG-3 + TIGIT.
J Allison-T Honjo 1996/2002 (Nobel 2018) CTLA-4 + PD-1 inhibition; modern modern ipilimumab + nivolumab + 2024 LAG-3 + TIGIT.